DekaBank Deutsche Girozentrale’s TG Therapeutics TGTX Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio TGTX Stock Details TGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$121K	Hold	3,724	–	–	﹤0.01%	1007
2026 Q1	$124K	Hold	3,724	–	–	﹤0.01%	1008
2025 Q4	$55K	Hold	3,724	–	–	﹤0.01%	1319
2025 Q3	$136K	Hold	3,724	–	–	﹤0.01%	1188
2025 Q2	$136K	Hold	3,724	–	–	﹤0.01%	1187
2025 Q1	$142K	Hold	3,724	–	–	﹤0.01%	1168
2024 Q4	$120K	Hold	3,724	–	–	﹤0.01%	1228
2024 Q3	$88K	Hold	3,724	–	–	﹤0.01%	1287
2024 Q2	$66K	Hold	3,724	–	–	﹤0.01%	1349
2024 Q1	$58K	Buy	+3,724	New	+$59.3K	﹤0.01%	1350
2023 Q3	–	Sell	-42,000	Closed	-$1.01M	–	1525
2023 Q2	$1.01M	Hold	42,000	–	–	﹤0.01%	880
2023 Q1	$608K	Buy	+42,000	New	+$638K	﹤0.01%	977

Other funds holding TGTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return

DekaBank Deutsche Girozentrale's TGTX Position: Q2 2026 in Review

DekaBank Deutsche Girozentrale held its TG Therapeutics (TGTX) position steady in Q2 2026 at 3,724 shares worth $121K. The position accounts for ﹤0.01% of the portfolio, ranked #1007.

DekaBank Deutsche Girozentrale first reported a position in TGTX in Q1 2023 and has held it in 12 quarters since. The position peaked at $1.01M in Q2 2023. 431 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

DekaBank Deutsche Girozentrale held 3,724 shares of TG Therapeutics worth $121K as of Q2 2026.
DekaBank Deutsche Girozentrale left its TG Therapeutics share count unchanged in Q2 2026.
TG Therapeutics made up ﹤0.01% of DekaBank Deutsche Girozentrale's portfolio in Q2 2026, its #1007 holding.
DekaBank Deutsche Girozentrale first reported a position in TG Therapeutics in Q1 2023 and has held it in 12 quarters since.
DekaBank Deutsche Girozentrale's TG Therapeutics position peaked at $1.01M in Q2 2023.
431 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2026, filed 5 Aug 2026.